BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17215685)

  • 1. An update on opsoclonus.
    Wong A
    Curr Opin Neurol; 2007 Feb; 20(1):25-31. PubMed ID: 17215685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paraneoplastic opsoclonus-myoclonus syndrome--a review].
    Matsumoto H; Ugawa Y
    Brain Nerve; 2010 Apr; 62(4):365-9. PubMed ID: 20420176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma.
    Raffaghello L; Conte M; De Grandis E; Pistoia V
    Eur J Paediatr Neurol; 2009 May; 13(3):219-23. PubMed ID: 18571942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates.
    Wong AM; Musallam S; Tomlinson RD; Shannon P; Sharpe JA
    J Neurol Sci; 2001 Aug; 189(1-2):71-81. PubMed ID: 11535236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsoclonus-myoclonus syndrome and HIV-infection.
    Scott KM; Parker F; Heckmann JM
    J Neurol Sci; 2009 Sep; 284(1-2):192-5. PubMed ID: 19419738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New autoantibodies in pediatric opsoclonus myoclonus syndrome.
    Kirsten A; Beck S; Fühlhuber V; Kaps M; Kreutz T; Korfei M; Schmitt S; Preissner KT; Blaes F
    Ann N Y Acad Sci; 2007 Sep; 1110():256-60. PubMed ID: 17911440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonazepam responsive opsoclonus myoclonus syndrome: additional evidence in favour of fastigial nucleus disinhibition hypothesis?
    Paliwal VK; Chandra S; Verma R; Kalita J; Misra UK
    J Neural Transm (Vienna); 2010 May; 117(5):613-5. PubMed ID: 20094737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuro-ophthalmologic manifestations of paraneoplastic syndromes.
    Ko MW; Dalmau J; Galetta SL
    J Neuroophthalmol; 2008 Mar; 28(1):58-68. PubMed ID: 18347462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
    Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S
    J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the fastigial nucleus in saccadic eye oscillations.
    Helmchen C; Rambold H; Erdmann C; Mohr C; Sprenger A; Binkofski F
    Ann N Y Acad Sci; 2003 Oct; 1004():229-40. PubMed ID: 14662462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccadic intrusions: review and update.
    Lemos J; Eggenberger E
    Curr Opin Neurol; 2013 Feb; 26(1):59-66. PubMed ID: 23302805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
    Chang BH; Koch T; Hopkins K; Malempati S
    Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsoclonus-myoclonus associated with celiac disease.
    Deconinck N; Scaillon M; Segers V; Groswasser JJ; Dan B
    Pediatr Neurol; 2006 Apr; 34(4):312-4. PubMed ID: 16638509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of opsoclonus-myoclonus syndrome associated with anti-central nervous system antibody].
    Ushiyama M; Ishida K; Ikeda S; Imai H; Yanagisawa N
    Rinsho Shinkeigaku; 1994 Sep; 34(9):898-902. PubMed ID: 7820964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar activation in opsoclonus: an fMRI study.
    Helmchen C; Rambold H; Sprenger A; Erdmann C; Binkofski F;
    Neurology; 2003 Aug; 61(3):412-5. PubMed ID: 12913213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain volumetric analysis and cortical thickness in adults with saccadic intrusions (ocular flutter or opsoclonus-myoclonus syndrome).
    Ibáñez-Juliá MJ; Pappa E; Gaymard B; Leclercq D; Hautefort C; Tilikete C; Delattre JY; Hoang-Xuan K; Psimaras D; Alentorn A
    Clin Neurol Neurosurg; 2017 Dec; 163():167-172. PubMed ID: 29121544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome.
    Wessig C; Klein R; Schneider MF; Toyka KV; Naumann M; Sommer C
    Neurology; 2003 Jul; 61(2):195-8. PubMed ID: 12874398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome.
    Panzer JA; Anand R; Dalmau J; Lynch DR
    J Neuroimmunol; 2015 Sep; 286():86-92. PubMed ID: 26298330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and pathological study of anti-Ri-associated encephalopathy.
    Hormigo A; Dalmau J; Rosenblum MK; River ME; Posner JB
    Ann Neurol; 1994 Dec; 36(6):896-902. PubMed ID: 7998777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
    Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F
    Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.